nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—Infarction—Ramipril—type 1 diabetes mellitus	0.026	0.0583	CcSEcCtD
Sumatriptan—Lower respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.0211	0.0473	CcSEcCtD
Sumatriptan—Cerebral ischaemia—Ramipril—type 1 diabetes mellitus	0.0149	0.0335	CcSEcCtD
Sumatriptan—Transient ischaemic attack—Ramipril—type 1 diabetes mellitus	0.0143	0.032	CcSEcCtD
Sumatriptan—Sleep disturbance—Ramipril—type 1 diabetes mellitus	0.0129	0.0288	CcSEcCtD
Sumatriptan—Neuralgia—Ramipril—type 1 diabetes mellitus	0.0104	0.0233	CcSEcCtD
Sumatriptan—Burning sensation—Ramipril—type 1 diabetes mellitus	0.0104	0.0233	CcSEcCtD
Sumatriptan—Myocardial ischaemia—Ramipril—type 1 diabetes mellitus	0.00897	0.0201	CcSEcCtD
Sumatriptan—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.00757	0.017	CcSEcCtD
Sumatriptan—Vasculitis—Ramipril—type 1 diabetes mellitus	0.00739	0.0166	CcSEcCtD
Sumatriptan—HTR3A—nerve—type 1 diabetes mellitus	0.00709	0.143	CbGeAlD
Sumatriptan—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.007	0.0157	CcSEcCtD
Sumatriptan—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.00645	0.0145	CcSEcCtD
Sumatriptan—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00604	0.0136	CcSEcCtD
Sumatriptan—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00596	0.0134	CcSEcCtD
Sumatriptan—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.0059	0.0132	CcSEcCtD
Sumatriptan—Deafness—Ramipril—type 1 diabetes mellitus	0.00585	0.0131	CcSEcCtD
Sumatriptan—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.0058	0.013	CcSEcCtD
Sumatriptan—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00567	0.0127	CcSEcCtD
Sumatriptan—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00552	0.0124	CcSEcCtD
Sumatriptan—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.00541	0.0121	CcSEcCtD
Sumatriptan—Arthritis—Ramipril—type 1 diabetes mellitus	0.00538	0.0121	CcSEcCtD
Sumatriptan—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00536	0.012	CcSEcCtD
Sumatriptan—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00534	0.012	CcSEcCtD
Sumatriptan—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.00483	0.0108	CcSEcCtD
Sumatriptan—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00471	0.0106	CcSEcCtD
Sumatriptan—Gastritis—Ramipril—type 1 diabetes mellitus	0.00463	0.0104	CcSEcCtD
Sumatriptan—Influenza—Ramipril—type 1 diabetes mellitus	0.00452	0.0101	CcSEcCtD
Sumatriptan—Asthma—Ramipril—type 1 diabetes mellitus	0.00452	0.0101	CcSEcCtD
Sumatriptan—Dysphagia—Ramipril—type 1 diabetes mellitus	0.00452	0.0101	CcSEcCtD
Sumatriptan—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00445	0.00998	CcSEcCtD
Sumatriptan—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00443	0.00995	CcSEcCtD
Sumatriptan—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00441	0.00988	CcSEcCtD
Sumatriptan—MAOA—nerve—type 1 diabetes mellitus	0.00438	0.0883	CbGeAlD
Sumatriptan—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00435	0.00976	CcSEcCtD
Sumatriptan—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00434	0.00973	CcSEcCtD
Sumatriptan—DRD2—nerve—type 1 diabetes mellitus	0.00433	0.0874	CbGeAlD
Sumatriptan—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00429	0.00964	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.00413	0.00926	CcSEcCtD
Sumatriptan—Weight increased—Ramipril—type 1 diabetes mellitus	0.00412	0.00923	CcSEcCtD
Sumatriptan—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00397	0.00892	CcSEcCtD
Sumatriptan—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00395	0.00887	CcSEcCtD
Sumatriptan—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00392	0.00879	CcSEcCtD
Sumatriptan—Sweating—Ramipril—type 1 diabetes mellitus	0.00387	0.00867	CcSEcCtD
Sumatriptan—Epistaxis—Ramipril—type 1 diabetes mellitus	0.0038	0.00853	CcSEcCtD
Sumatriptan—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00378	0.00849	CcSEcCtD
Sumatriptan—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.00356	0.00798	CcSEcCtD
Sumatriptan—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00349	0.00783	CcSEcCtD
Sumatriptan—HTR3A—islet of Langerhans—type 1 diabetes mellitus	0.00343	0.0692	CbGeAlD
Sumatriptan—Tinnitus—Ramipril—type 1 diabetes mellitus	0.00337	0.00757	CcSEcCtD
Sumatriptan—Flushing—Ramipril—type 1 diabetes mellitus	0.00336	0.00754	CcSEcCtD
Sumatriptan—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.00327	0.00734	CcSEcCtD
Sumatriptan—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00326	0.00732	CcSEcCtD
Sumatriptan—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00323	0.00725	CcSEcCtD
Sumatriptan—Erythema—Ramipril—type 1 diabetes mellitus	0.00315	0.00707	CcSEcCtD
Sumatriptan—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00309	0.00692	CcSEcCtD
Sumatriptan—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00303	0.0068	CcSEcCtD
Sumatriptan—Tremor—Ramipril—type 1 diabetes mellitus	0.00295	0.00662	CcSEcCtD
Sumatriptan—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00292	0.00656	CcSEcCtD
Sumatriptan—Agitation—Ramipril—type 1 diabetes mellitus	0.0029	0.0065	CcSEcCtD
Sumatriptan—Angioedema—Ramipril—type 1 diabetes mellitus	0.00288	0.00646	CcSEcCtD
Sumatriptan—Malaise—Ramipril—type 1 diabetes mellitus	0.00284	0.00638	CcSEcCtD
Sumatriptan—Vertigo—Ramipril—type 1 diabetes mellitus	0.00283	0.00635	CcSEcCtD
Sumatriptan—Syncope—Ramipril—type 1 diabetes mellitus	0.00283	0.00634	CcSEcCtD
Sumatriptan—Palpitations—Ramipril—type 1 diabetes mellitus	0.00278	0.00625	CcSEcCtD
Sumatriptan—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.00277	0.00621	CcSEcCtD
Sumatriptan—Cough—Ramipril—type 1 diabetes mellitus	0.00275	0.00617	CcSEcCtD
Sumatriptan—Convulsion—Ramipril—type 1 diabetes mellitus	0.00273	0.00613	CcSEcCtD
Sumatriptan—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00268	0.00602	CcSEcCtD
Sumatriptan—Myalgia—Ramipril—type 1 diabetes mellitus	0.00268	0.00602	CcSEcCtD
Sumatriptan—Chest pain—Ramipril—type 1 diabetes mellitus	0.00268	0.00602	CcSEcCtD
Sumatriptan—Anxiety—Ramipril—type 1 diabetes mellitus	0.00267	0.006	CcSEcCtD
Sumatriptan—Discomfort—Ramipril—type 1 diabetes mellitus	0.00265	0.00595	CcSEcCtD
Sumatriptan—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00262	0.00589	CcSEcCtD
Sumatriptan—Confusional state—Ramipril—type 1 diabetes mellitus	0.00259	0.00582	CcSEcCtD
Sumatriptan—Oedema—Ramipril—type 1 diabetes mellitus	0.00257	0.00577	CcSEcCtD
Sumatriptan—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.00257	0.00577	CcSEcCtD
Sumatriptan—Shock—Ramipril—type 1 diabetes mellitus	0.00253	0.00568	CcSEcCtD
Sumatriptan—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00252	0.00566	CcSEcCtD
Sumatriptan—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00252	0.00565	CcSEcCtD
Sumatriptan—Tachycardia—Ramipril—type 1 diabetes mellitus	0.00251	0.00563	CcSEcCtD
Sumatriptan—Skin disorder—Ramipril—type 1 diabetes mellitus	0.0025	0.0056	CcSEcCtD
Sumatriptan—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.00249	0.00558	CcSEcCtD
Sumatriptan—Hypotension—Ramipril—type 1 diabetes mellitus	0.0024	0.00539	CcSEcCtD
Sumatriptan—SLCO1B1—kidney—type 1 diabetes mellitus	0.00236	0.0475	CbGeAlD
Sumatriptan—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00234	0.00526	CcSEcCtD
Sumatriptan—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00231	0.00518	CcSEcCtD
Sumatriptan—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00229	0.00514	CcSEcCtD
Sumatriptan—Somnolence—Ramipril—type 1 diabetes mellitus	0.00229	0.00513	CcSEcCtD
Sumatriptan—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00224	0.00502	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.00222	0.00498	CcSEcCtD
Sumatriptan—Fatigue—Ramipril—type 1 diabetes mellitus	0.00222	0.00497	CcSEcCtD
Sumatriptan—Constipation—Ramipril—type 1 diabetes mellitus	0.0022	0.00493	CcSEcCtD
Sumatriptan—MAOA—islet of Langerhans—type 1 diabetes mellitus	0.00212	0.0428	CbGeAlD
Sumatriptan—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00212	0.00475	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.0021	0.00472	CcSEcCtD
Sumatriptan—HTR1B—cardiovascular system—type 1 diabetes mellitus	0.00208	0.042	CbGeAlD
Sumatriptan—Urticaria—Ramipril—type 1 diabetes mellitus	0.00204	0.00458	CcSEcCtD
Sumatriptan—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00203	0.00456	CcSEcCtD
Sumatriptan—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00203	0.00456	CcSEcCtD
Sumatriptan—HTR1D—cardiovascular system—type 1 diabetes mellitus	0.00202	0.0406	CbGeAlD
Sumatriptan—HTR1D—kidney—type 1 diabetes mellitus	0.00197	0.0398	CbGeAlD
Sumatriptan—SLCO1A2—kidney—type 1 diabetes mellitus	0.00192	0.0386	CbGeAlD
Sumatriptan—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00189	0.00425	CcSEcCtD
Sumatriptan—Asthenia—Ramipril—type 1 diabetes mellitus	0.00185	0.00414	CcSEcCtD
Sumatriptan—Pruritus—Ramipril—type 1 diabetes mellitus	0.00182	0.00408	CcSEcCtD
Sumatriptan—MAOA—retina—type 1 diabetes mellitus	0.00182	0.0366	CbGeAlD
Sumatriptan—DRD2—retina—type 1 diabetes mellitus	0.0018	0.0362	CbGeAlD
Sumatriptan—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00176	0.00395	CcSEcCtD
Sumatriptan—MAOA—nephron tubule—type 1 diabetes mellitus	0.00171	0.0345	CbGeAlD
Sumatriptan—Dizziness—Ramipril—type 1 diabetes mellitus	0.0017	0.00382	CcSEcCtD
Sumatriptan—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.00168	0.0339	CbGeAlD
Sumatriptan—Vomiting—Ramipril—type 1 diabetes mellitus	0.00164	0.00367	CcSEcCtD
Sumatriptan—Rash—Ramipril—type 1 diabetes mellitus	0.00162	0.00364	CcSEcCtD
Sumatriptan—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00162	0.00363	CcSEcCtD
Sumatriptan—Headache—Ramipril—type 1 diabetes mellitus	0.00161	0.00361	CcSEcCtD
Sumatriptan—MAOA—cardiovascular system—type 1 diabetes mellitus	0.00154	0.0309	CbGeAlD
Sumatriptan—Nausea—Ramipril—type 1 diabetes mellitus	0.00153	0.00343	CcSEcCtD
Sumatriptan—MAOA—kidney—type 1 diabetes mellitus	0.0015	0.0303	CbGeAlD
Sumatriptan—MAOA—pancreas—type 1 diabetes mellitus	0.00149	0.0301	CbGeAlD
Sumatriptan—ABCG2—nephron tubule—type 1 diabetes mellitus	0.00148	0.0299	CbGeAlD
Sumatriptan—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000908	0.0183	CbGeAlD
Sumatriptan—ABCB1—retina—type 1 diabetes mellitus	0.000776	0.0156	CbGeAlD
Sumatriptan—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000731	0.0147	CbGeAlD
Sumatriptan—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000656	0.0132	CbGeAlD
Sumatriptan—ABCB1—kidney—type 1 diabetes mellitus	0.000642	0.0129	CbGeAlD
Sumatriptan—ABCB1—pancreas—type 1 diabetes mellitus	0.000638	0.0129	CbGeAlD
Sumatriptan—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000552	0.0111	CbGeAlD
Sumatriptan—MAOA—Metabolism—ITPR3—type 1 diabetes mellitus	0.000206	0.000407	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GSTT1—type 1 diabetes mellitus	0.000204	0.000404	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000203	0.000403	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000203	0.000403	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000203	0.000403	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000202	0.000401	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000199	0.000395	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.000199	0.000394	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000196	0.000389	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000196	0.000388	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000196	0.000388	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—HBA1—type 1 diabetes mellitus	0.000194	0.000383	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000193	0.000383	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—APOC3—type 1 diabetes mellitus	0.000192	0.000381	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000192	0.00038	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000192	0.00038	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000191	0.000378	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00019	0.000377	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.00019	0.000376	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ITPR3—type 1 diabetes mellitus	0.00019	0.000376	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000189	0.000375	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GSTT1—type 1 diabetes mellitus	0.000189	0.000374	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000188	0.000372	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000187	0.00037	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000186	0.000369	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000186	0.000368	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000184	0.000365	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000183	0.000363	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000183	0.000363	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000183	0.000362	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000181	0.000359	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000181	0.000358	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000179	0.000356	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000179	0.000356	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000179	0.000354	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—HBA1—type 1 diabetes mellitus	0.000179	0.000354	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000178	0.000353	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000178	0.000352	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—APOC3—type 1 diabetes mellitus	0.000177	0.000352	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ITPR3—type 1 diabetes mellitus	0.000176	0.000348	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000176	0.000348	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000175	0.000347	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000175	0.000347	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	0.000175	0.000346	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000175	0.000346	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000174	0.000345	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000174	0.000345	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000173	0.000344	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000173	0.000343	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000173	0.000343	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000173	0.000343	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000172	0.000341	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000169	0.000336	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000169	0.000335	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000169	0.000335	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000169	0.000334	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—HBA1—type 1 diabetes mellitus	0.000165	0.000328	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000165	0.000327	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—APOC3—type 1 diabetes mellitus	0.000164	0.000326	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000164	0.000325	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000164	0.000324	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000163	0.000323	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000163	0.000323	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—GCG—type 1 diabetes mellitus	0.000162	0.000322	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000162	0.000321	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GSTT1—type 1 diabetes mellitus	0.000161	0.00032	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SST—type 1 diabetes mellitus	0.000161	0.000319	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000161	0.000318	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00016	0.000317	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.00016	0.000317	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000159	0.000315	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000159	0.000314	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SST—type 1 diabetes mellitus	0.000158	0.000312	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000157	0.000311	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000156	0.00031	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000154	0.000305	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000153	0.000303	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000153	0.000303	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000152	0.000301	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000152	0.000301	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—GCG—type 1 diabetes mellitus	0.00015	0.000298	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000149	0.000295	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000148	0.000294	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000146	0.00029	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000144	0.000286	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000143	0.000284	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000143	0.000283	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000142	0.000282	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000142	0.000282	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000142	0.000282	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000141	0.00028	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00014	0.000278	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—GCG—type 1 diabetes mellitus	0.000139	0.000275	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000138	0.000274	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000138	0.000273	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CAT—type 1 diabetes mellitus	0.000137	0.000272	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000137	0.000271	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000137	0.000271	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000135	0.000268	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000134	0.000266	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000134	0.000265	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000133	0.000264	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000131	0.00026	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000131	0.000259	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000131	0.000259	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000129	0.000256	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—GCG—type 1 diabetes mellitus	0.000129	0.000255	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000128	0.000254	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CAT—type 1 diabetes mellitus	0.000127	0.000252	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000127	0.000251	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—INS—type 1 diabetes mellitus	0.000126	0.00025	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000125	0.000247	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000122	0.000242	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000122	0.000241	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000121	0.000241	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000121	0.00024	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000121	0.000239	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00012	0.000238	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00012	0.000238	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SST—type 1 diabetes mellitus	0.00012	0.000238	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000119	0.000237	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	0.000119	0.000237	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000119	0.000236	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000119	0.000236	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CAT—type 1 diabetes mellitus	0.000118	0.000233	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000117	0.000232	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000115	0.000228	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000114	0.000227	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	0.000114	0.000225	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000113	0.000224	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000113	0.000223	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000113	0.000223	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000112	0.000221	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000111	0.00022	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000111	0.000219	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000109	0.000217	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CAT—type 1 diabetes mellitus	0.000109	0.000216	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000109	0.000215	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000107	0.000212	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000105	0.000209	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SST—type 1 diabetes mellitus	0.000105	0.000209	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000105	0.000208	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000104	0.000205	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000103	0.000205	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000103	0.000204	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000102	0.000202	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000102	0.000201	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000101	0.000201	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.0001	0.000198	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.0001	0.000198	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	9.97e-05	0.000198	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL2—type 1 diabetes mellitus	9.93e-05	0.000197	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	9.5e-05	0.000188	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GCG—type 1 diabetes mellitus	9.39e-05	0.000186	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CASP3—type 1 diabetes mellitus	9.38e-05	0.000186	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL2—type 1 diabetes mellitus	9.37e-05	0.000186	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—IL6—type 1 diabetes mellitus	9.32e-05	0.000185	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—INS—type 1 diabetes mellitus	9.13e-05	0.000181	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.09e-05	0.00018	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.06e-05	0.000179	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	9.04e-05	0.000179	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	8.94e-05	0.000177	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	8.89e-05	0.000176	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—VAV1—type 1 diabetes mellitus	8.78e-05	0.000174	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	8.76e-05	0.000173	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	8.73e-05	0.000173	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CD86—type 1 diabetes mellitus	8.72e-05	0.000173	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CD80—type 1 diabetes mellitus	8.53e-05	0.000169	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—INS—type 1 diabetes mellitus	8.46e-05	0.000168	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ALB—type 1 diabetes mellitus	8.37e-05	0.000166	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CD80—type 1 diabetes mellitus	8.35e-05	0.000165	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.33e-05	0.000165	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.27e-05	0.000164	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—INS—type 1 diabetes mellitus	8.06e-05	0.00016	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—NOS3—type 1 diabetes mellitus	8e-05	0.000159	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.98e-05	0.000158	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF2—type 1 diabetes mellitus	7.95e-05	0.000158	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—INS—type 1 diabetes mellitus	7.89e-05	0.000156	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—STAT3—type 1 diabetes mellitus	7.88e-05	0.000156	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.86e-05	0.000156	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—INS—type 1 diabetes mellitus	7.8e-05	0.000155	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.79e-05	0.000154	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.76e-05	0.000154	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ALB—type 1 diabetes mellitus	7.75e-05	0.000154	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.73e-05	0.000153	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CD86—type 1 diabetes mellitus	7.66e-05	0.000152	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	7.65e-05	0.000152	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.63e-05	0.000151	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.62e-05	0.000151	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	7.59e-05	0.00015	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.56e-05	0.00015	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—NOS3—type 1 diabetes mellitus	7.42e-05	0.000147	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	7.31e-05	0.000145	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.27e-05	0.000144	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—INS—type 1 diabetes mellitus	7.23e-05	0.000143	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.2e-05	0.000143	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EGFR—type 1 diabetes mellitus	7.16e-05	0.000142	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ALB—type 1 diabetes mellitus	7.15e-05	0.000142	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	7.07e-05	0.00014	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	7.05e-05	0.00014	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	6.95e-05	0.000138	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.92e-05	0.000137	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.9e-05	0.000137	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—NOS3—type 1 diabetes mellitus	6.84e-05	0.000136	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.79e-05	0.000135	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.69e-05	0.000133	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.64e-05	0.000132	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ALB—type 1 diabetes mellitus	6.62e-05	0.000131	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	6.36e-05	0.000126	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—NOS3—type 1 diabetes mellitus	6.34e-05	0.000126	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	6.01e-05	0.000119	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	6e-05	0.000119	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL2—type 1 diabetes mellitus	5.99e-05	0.000119	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.96e-05	0.000118	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	5.89e-05	0.000117	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.87e-05	0.000116	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL2—type 1 diabetes mellitus	5.87e-05	0.000116	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.84e-05	0.000116	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.81e-05	0.000115	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.79e-05	0.000115	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	5.59e-05	0.000111	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—IL6—type 1 diabetes mellitus	5.51e-05	0.000109	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.37e-05	0.000106	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	5.28e-05	0.000105	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.27e-05	0.000104	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.1e-05	0.000101	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.08e-05	0.000101	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	5.04e-05	9.99e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.94e-05	9.78e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.72e-05	9.34e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.63e-05	9.17e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.58e-05	9.08e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.49e-05	8.89e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.48e-05	8.87e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.47e-05	8.85e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.45e-05	8.81e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.93e-05	7.79e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	3.92e-05	7.77e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—INS—type 1 diabetes mellitus	3.91e-05	7.74e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.9e-05	7.74e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.76e-05	7.45e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	3.58e-05	7.1e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—IL6—type 1 diabetes mellitus	3.52e-05	6.98e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.45e-05	6.83e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	3.43e-05	6.79e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.42e-05	6.77e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.3e-05	6.54e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	3e-05	5.95e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.63e-05	5.2e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.31e-05	4.57e-05	CbGpPWpGaD
